376 related articles for article (PubMed ID: 35556159)
21. [
Chen L; Zhong X; Li L; Li X; Liu Y; Guo C; Chen Y; Huang Z
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1360-1370. PubMed ID: 36631715
[TBL] [Abstract][Full Text] [Related]
22. Head-to-head Intra-individual Comparison of [
Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
[TBL] [Abstract][Full Text] [Related]
23. The potential utility of [
Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
[TBL] [Abstract][Full Text] [Related]
24. Comparison of
Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
[TBL] [Abstract][Full Text] [Related]
25. Comparison of
Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
[TBL] [Abstract][Full Text] [Related]
26.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
27. Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model.
Pirasteh A; Periyasamy S; Meudt JJ; Liu Y; Lee LM; Schachtschneider KM; Schook LB; Gaba RC; Mao L; Said A; McMillan AB; Laeseke PF; Shanmuganayagam D
J Nucl Med; 2022 Dec; 63(12):1956-1961. PubMed ID: 35450958
[TBL] [Abstract][Full Text] [Related]
28.
Röhrich M; Syed M; Liew DP; Giesel FL; Liermann J; Choyke PL; Wefers AK; Ritz T; Szymbara M; Schillings L; Heger U; Rathke H; Kratochwil C; Huber PE; von Deimling A; Debus J; Kauczor HU; Haberkorn U; Adeberg S
Radiother Oncol; 2021 Jul; 160():192-201. PubMed ID: 33940087
[TBL] [Abstract][Full Text] [Related]
29. Visualization of thermal damage using
Kupusovic J; Kessler L; Nekolla SG; Riesinger L; Weber MM; Ferdinandus J; Kochhäuser S; Rassaf T; Wakili R; Rischpler C; Siebermair J
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1553-1559. PubMed ID: 34778928
[TBL] [Abstract][Full Text] [Related]
30. Improved cancer detection in Waldeyer's tonsillar ring by
Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
[TBL] [Abstract][Full Text] [Related]
31. Initial Results of
Backhaus P; Burg MC; Asmus I; Pixberg M; Büther F; Breyholz HJ; Yeh R; Weigel SB; Stichling P; Heindel W; Bobe S; Barth P; Tio J; Schäfers M
J Nucl Med; 2023 May; 64(5):717-723. PubMed ID: 36396458
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer.
Backhaus P; Burg MC; Roll W; Büther F; Breyholz HJ; Weigel S; Heindel W; Pixberg M; Barth P; Tio J; Schäfers M
Radiology; 2022 Jan; 302(1):39-47. PubMed ID: 34636633
[TBL] [Abstract][Full Text] [Related]
33. Biodistribution, pharmacokinetics, dosimetry of [
Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
[TBL] [Abstract][Full Text] [Related]
34.
Fu H; Wu J; Huang J; Sun L; Wu H; Guo W; Qiu S; Chen H
Radiology; 2022 Aug; 304(2):397-405. PubMed ID: 35536131
[TBL] [Abstract][Full Text] [Related]
35. Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [
Du X; Gu B; Wang X; Wang X; Ji M; Zhang J; He S; Xu X; Yang Z; Song S
Mol Pharm; 2024 Feb; 21(2):904-915. PubMed ID: 38179677
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [
Huang J; Fu L; Zhang X; Huang S; Dong Y; Hu K; Han Y; Zhou K; Min C; Huang Y; Tang G
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3363-3374. PubMed ID: 37266596
[TBL] [Abstract][Full Text] [Related]
37. Enhancing Clinical Diagnosis for Patients With Persistent Pulmonary Abnormalities After COVID-19 Infection: The Potential Benefit of 68 Ga-FAPI PET/CT.
Sviridenko A; Boehm A; di Santo G; Uprimny C; Nilica B; Fritz J; Giesel FL; Haberkorn U; Sahanic S; Decristoforo C; Tancevski I; Widmann G; Loeffler-Ragg J; Virgolini I
Clin Nucl Med; 2022 Dec; 47(12):1026-1029. PubMed ID: 36257062
[TBL] [Abstract][Full Text] [Related]
38. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [
Chen R; Yang X; Yu X; Zhou X; Ng YL; Zhao H; Li L; Huang G; Zhou Y; Liu J
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):929-936. PubMed ID: 36334106
[TBL] [Abstract][Full Text] [Related]
39. Molecular imaging of fibroblast activity in pressure overload heart failure using [
Wang G; Yang Q; Wu S; Xu X; Li X; Liang S; Pan G; Zuo C; Zhao X; Cheng C; Liu S
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):465-474. PubMed ID: 36171409
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast Activation Protein-Targeted PET/CT with
Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F
J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
